Parenteral Nutrition Associated Liver Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Parenteral Nutrition Associated Liver Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06274788

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome…

This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source…

United States40 participantsStarted 2024-12-15

Treatment: Omegaven® (fish oil triglycerides) Injectable Emulsion

All recent trials (43 shown)

CompletedPhase 3

NCT01194063

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.

United States36 participantsStarted 2010-10-20

Treatment: Omega-3 fish oil lipid emulsion

APPROVED_FOR_MARKETINGNot Applicable

NCT02929303

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

This is an expanded access protocol for use of intravenous fish oil infusion, Omegaven, in infants and children with parenteral nutrition associated liver disea…

United States

Treatment: Omegaven IV lipid emulsion

Parenteral Nutrition Associated Liver Disease

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome…

All recent trials (43 shown)

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome…

All recent trials (43 shown)

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

Cholestasis Reversal: Efficacy of IV Fish Oil

Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants

Study of NST-6179 in Healthy Subjects

Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-…

How Well do we Feed the Critically Ill Patients

Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-…

Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease

Omegaven Protocol:Intermediate Size Patient Population

Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis

Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease

Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD

A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease

Compassionate Use of Omegaven IV Fat Emulsion

Compassionate Use of Omegaven in Children